Skip to menu Skip to content Skip to footer
Professor Dan Siskind
Professor

Dan Siskind

Email: 
Phone: 
+61 7 3176 2860

Overview

Background

Prof Siskind trained as a psychiatrist in Australia and the United States. He graduated from medicine at the University of Queensland in 1998. After working with Doctors Without Borders in Chechnya in 2000, he became interested in psychiatry. He moved to Boston in 2002, where he did his psychiatry residency at Boston University and a Master of Public Health at Harvard University. He returned to Brisbane in June 2008 as a clinical academic psychiatrist at the Metro South Addiction and Mental Health Service. He completed his Ph.D in Feb 2014. His research interests include clozapine and treatment refractory schizophrenia, the physical health of people with severe and persistent mental illness, supported accommodation, assertive community treatment and mental health services research. He has been awarded an NHMRC Investigator Grant as an Emerging Leadership Fellow (2021-2025) and held an NHMRC Early Career Fellowship (2016-2019). He has a current CIA MRFF RCRDUN grant looking at treatments to reduce cardiometabolic morbidity among people with schizophrenia. He has over 200 peer reviewed publications, including first author in the highly ranked Lancet, World Psychiatry, Lancet Psychiatry, BJPsych, ANZJP, & Schizophrenia Bulletin. He is a named investigator on over $40 million in competitive research grants, with over $6 million as CIA.

Availability

Professor Dan Siskind is:
Available for supervision
Media expert

Fields of research

Research interests

  • Schizophrenia

  • Physical Health Comorbidity

Works

Search Professor Dan Siskind’s works on UQ eSpace

376 works between 2007 and 2025

241 - 260 of 376 works

2018

Journal Article

High rates of respiratory symptoms and airway disease in mental health inpatients in a tertiary centre

Burke, Andrew J., Hay, Karen, Chadwick, Alex, Siskind, Dan and Sheridan, Judith (2018). High rates of respiratory symptoms and airway disease in mental health inpatients in a tertiary centre. Internal Medicine Journal, 48 (4), 433-438. doi: 10.1111/imj.13594

High rates of respiratory symptoms and airway disease in mental health inpatients in a tertiary centre

2018

Journal Article

Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014

Hollingworth, Samantha A., Winckel, Karl, Saiepour, Nargess, Wheeler, Amanda J., Myles, Nicholas and Siskind, Dan (2018). Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014. Psychopharmacology, 235 (7), 1915-1921. doi: 10.1007/s00213-018-4881-0

Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014

2018

Journal Article

Disentangling schizophrenia spectrum disorders

Suetani, S., Siskind, D., Scott, J. G. and McGrath, J. J. (2018). Disentangling schizophrenia spectrum disorders. Acta Psychiatrica Scandinavica, 137 (4), 365-366. doi: 10.1111/acps.12865

Disentangling schizophrenia spectrum disorders

2018

Journal Article

CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapine

Siskind, Dan, Friend, Nadia, Russell, Anthony, McGrath, John J., Lim, Carmen, Patterson, Sue, Flaws, Dylan, Stedman, Terry, Moudgil, Vikas, Sardinha, Savio, Suetani, Shuichi, Kisely, Steve, Winckel, Karl and Baker, Andrea (2018). CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapine. BMJ Open, 8 (3) e021000, e021000. doi: 10.1136/bmjopen-2017-021000

CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapine

2018

Journal Article

Metformin prescription in psychiatry

Suetani, Shuichi, Parker, Stephen, Korman, Nicole, Crompton, David, Dark, Frances and Siskind, Dan (2018). Metformin prescription in psychiatry. Australasian Psychiatry, 26 (1), 107-107. doi: 10.1177/1039856217726688

Metformin prescription in psychiatry

2018

Journal Article

Identifying characteristics and practices of multidisciplinary team reviews for patients with severe mental illness: a systematic review

Woody, Charlotte A., Baxter, Amanda J., Harris, Meredith G., Siskind, Dan J. and Whiteford, Harvey A. (2018). Identifying characteristics and practices of multidisciplinary team reviews for patients with severe mental illness: a systematic review. Australasian Psychiatry, 26 (3), 1039856217751783-275. doi: 10.1177/1039856217751783

Identifying characteristics and practices of multidisciplinary team reviews for patients with severe mental illness: a systematic review

2018

Conference Publication

Barriers and Enablers to Primary Care for Patients with Severe and Persistent Mental Illness

WIlliams, Ryan , Sturman, Nancy , Wyder, Marianne and Siskind, Dan (2018). Barriers and Enablers to Primary Care for Patients with Severe and Persistent Mental Illness. 60th Clinical Update, RACGP QLD, Brisbane QLD Australia, May 2018.

Barriers and Enablers to Primary Care for Patients with Severe and Persistent Mental Illness

2018

Conference Publication

Is deep brain stimulation a pacemaker for the brain? A systematic review and meta-analysis of its efficacy in depression

Kisely, S., Li, A., Warren, N. and Siskind, D. (2018). Is deep brain stimulation a pacemaker for the brain? A systematic review and meta-analysis of its efficacy in depression. RANZCP 2018 Congress, Auckland Convention Centre, 13-17 May 2018. London, United Kingdom: Sage Publications.

Is deep brain stimulation a pacemaker for the brain? A systematic review and meta-analysis of its efficacy in depression

2018

Conference Publication

Tips for consultants when supervising research projects with registrars and medical students

Siskind, D., Kisely, S., Parker, S. and Suetani, S. (2018). Tips for consultants when supervising research projects with registrars and medical students. RANZCP 2018 Congress, Auckland Convention Centre, 13-17 May 2018. London, United Kingdom: Sage Publications.

Tips for consultants when supervising research projects with registrars and medical students

2018

Conference Publication

Barriers and enablers to primary care for patients with severe and persistent mental illness

Williams, R., Siskind, D., Wyder, M. and Sturman, N. (2018). Barriers and enablers to primary care for patients with severe and persistent mental illness. GP18, Gold Coast, QLD, Australia, 11-13 October 2018.

Barriers and enablers to primary care for patients with severe and persistent mental illness

2018

Journal Article

Adverse cardiac events in out-patients initiating clozapine treatment: a nationwide register-based study

Rohde, C., Polcwiartek, C., Kragholm, K., Ebdrup, B. H., Siskind, D. and Nielsen, J. (2018). Adverse cardiac events in out-patients initiating clozapine treatment: a nationwide register-based study. Acta Psychiatrica Scandinavica, 137 (1), 47-53. doi: 10.1111/acps.12827

Adverse cardiac events in out-patients initiating clozapine treatment: a nationwide register-based study

2018

Conference Publication

Making supervision work: practical recommendations for supervisees

Parker, S., Suetani, S., Motamarri, B. and Siskind, D. (2018). Making supervision work: practical recommendations for supervisees. RANZCP 2018 Congress, Auckland Convention Centre, 13-17 May 2018. London, United Kingdom: Sage Publications.

Making supervision work: practical recommendations for supervisees

2018

Conference Publication

Evaluating effects of a healthy lifestyle intervention implemented at a residential mental health rehabilitation unit

Korman, N., Dodd, C., Suetani, S., Rosenbaum, S., Shah, S., Dark, F., Kendall, K. and Siskind, D. (2018). Evaluating effects of a healthy lifestyle intervention implemented at a residential mental health rehabilitation unit. RANZCP 2018 Congress, Auckland Convention Centre, 13-17 May 2018. London, United Kingdom: Sage Publications.

Evaluating effects of a healthy lifestyle intervention implemented at a residential mental health rehabilitation unit

2018

Conference Publication

What do meta-analyses tell us about clozapine's efficacy and effectiveness for treatment refractory schizophrenia?

Siskind, Dan, Kisely, Steve, Land, Rachel and McCartney, Lara (2018). What do meta-analyses tell us about clozapine's efficacy and effectiveness for treatment refractory schizophrenia?. 6th Biennial Conference of the Schizophrenia-International-Research-Society (SIRS), Florence Italy, 4-8 April 2018. Oxford, United Kingdom: Oxford University Press.

What do meta-analyses tell us about clozapine's efficacy and effectiveness for treatment refractory schizophrenia?

2018

Conference Publication

Treatment of clozapine-associated obesity and diabetes with exenatide (CODEX): a pilot randomised controlled trial

Siskind, D., Mayfield, K., Winckel, K., Hollingworth, S. and Kisely, S. (2018). Treatment of clozapine-associated obesity and diabetes with exenatide (CODEX): a pilot randomised controlled trial. SHPA MM2019, Brisbane, Australia, 22-25 November 2019.

Treatment of clozapine-associated obesity and diabetes with exenatide (CODEX): a pilot randomised controlled trial

2018

Conference Publication

Clozapine: when to start, how to augment and guidelines for management

O'Donaghue, B., Siskind, D., Warren, N. and Clark, S. (2018). Clozapine: when to start, how to augment and guidelines for management. RANZCP 2018 Congress, Auckland Convention Centre, 13-17 May 2018. London, United Kingdom: Sage Publications.

Clozapine: when to start, how to augment and guidelines for management

2018

Conference Publication

Building partnerships in academic psychiatry: a guide for new investigators and the scholarly project

Clark, S., Kisely, S., Parker, S., Harris, A., Suetani, S. and Siskind, D. (2018). Building partnerships in academic psychiatry: a guide for new investigators and the scholarly project. RANZCP 2018 Congress, Auckland Convention Centre, 13-17 May 2018. London, United Kingdom: Sage Publications.

Building partnerships in academic psychiatry: a guide for new investigators and the scholarly project

2018

Conference Publication

Treatment of clozapine-associated obesity and diabetes with exenatide (Codex) in adults with schizophrenia: a randomised controlled trial

Siskind, Dan, Russell, Anthony, Gamble, Clare, Winckel, Karl, Hollingworth, Sam and Kisely, Steve (2018). Treatment of clozapine-associated obesity and diabetes with exenatide (Codex) in adults with schizophrenia: a randomised controlled trial. 6th Biennial Conference of the Schizophrenia International Research Society (SIRS), Florence, Italy, 4-8 April 2018. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/schbul/sby016.436

Treatment of clozapine-associated obesity and diabetes with exenatide (Codex) in adults with schizophrenia: a randomised controlled trial

2017

Journal Article

Treatment of clozapine-associated obesity and diabetes with exenatide in adults with schizophrenia: A randomized controlled trial (CODEX)

Siskind, Dan J., Russell, Anthony W., Gamble, Clare, Winckel, Karl, Mayfield, Karla, Hollingworth, Sam, Hickman, Ingrid, Siskind, Victor and Kisely, Steve (2017). Treatment of clozapine-associated obesity and diabetes with exenatide in adults with schizophrenia: A randomized controlled trial (CODEX). Diabetes, obesity & metabolism, 20 (4), 1050-1055. doi: 10.1111/dom.13167

Treatment of clozapine-associated obesity and diabetes with exenatide in adults with schizophrenia: A randomized controlled trial (CODEX)

2017

Journal Article

Clozapine in primary care

Winckel, Karl and Siskind, Dan (2017). Clozapine in primary care. Australian Prescriber, 40 (6), 231-236. doi: 10.18773/austprescr.2017.067

Clozapine in primary care

Funding

Current funding

  • 2024 - 2028
    A hybrid-II implementation-effectiveness trial of a peer-supported self-management tool for young people in preparation for early intervention in psychosis service discharge (MY PREP-ED) (Ex USYD)
    Medical Research Futures Fund
    Open grant
  • 2023 - 2028
    Self-care of Multimorbidity in schizophrenia supported by Peer workers: a Co-designed health Information Technology (SiMPlicITy) (externally led NHMRC 2022 Targeted Call administered via Uni of Syd)
    University of Sydney
    Open grant
  • 2023 - 2027
    Using risk profiles to overcome challenges in incorporating polygenic risk scores into clinical mental health practice (QIMR administered MRFF Genomics Health Future Mission grant)
    Queensland Institute of Medical Research
    Open grant
  • 2022 - 2029
    Schizophrenia and Weight Improvement From Tirzepatide (SWIFT)
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant
  • 2021 - 2027
    Mental Health Australia General Clinical Trial Network (MAGNET) (MRFF Million Minds Mental Health Research Grant Led by Deakin University)
    Deakin University
    Open grant
  • 2021 - 2025
    Reducing the mortality gap for people with schizophrenia
    NHMRC Investigator Grants
    Open grant
  • 2020 - 2026
    Helping people with schizophrenia living longer, healthier lives
    Queensland Advancing Clinical Research Fellowship
    Open grant
  • 2019 - 2025
    What is the impact of the National Bowel Cancer Screening Program on colorectal cancer outcomes for people over the age of 50 with severe mental illness?
    Cancer Council Australia
    Open grant

Past funding

  • 2023 - 2024
    Cannabidiol (CBD) for Clozapine Refractory Schizophrenia (CanCloz)
    University of Sydney
    Open grant
  • 2022 - 2024
    A 40-year life course study of the effects of child maltreatment using linked birth cohort and administrative health data
    Metro South Health Research Support Scheme Project Grant
    Open grant
  • 2019 - 2021
    Identifying and treating patients with psychosis who are positive to anti-neuronal antibodies
    NHMRC Project Grant
    Open grant
  • 2019 - 2022
    Identifying and treating patients with psychosis who are positive to anti-neuronal antibodies (NHMRC Project Grant led by QIMR)
    Queensland Institute of Medical Research
    Open grant
  • 2018 - 2020
    The efficacy of adjunctive metformin to attenuate weight gain and visceral adiposity, and prevent conversion to diabetes in people with schizophrenia newly commenced on clozapine
    Society for Mental Health Research Inc
    Open grant
  • 2018 - 2019
    The efficacy of adjunctive metformin to attenuate weight gain and visceral adiposity, and prevent conversion to diabetes in people with schizophrenia newly commenced on clozapine
    The Australian Diabetes Society
    Open grant
  • 2017 - 2018
    Avant Doctors in Training Research Scholarship Program 2017
    Avant Mutual Group Limited
    Open grant
  • 2017 - 2019
    A comparison study of three physical activity measurement tools examining acceptability in people with psychotic disorders
    Society for Mental Health Research Inc
    Open grant
  • 2017 - 2019
    Acceptability of physical activity measures in people with psychotic disorders
    Royal Australian & New Zealand College Psychiatrists
    Open grant
  • 2016 - 2019
    Cardiometabolic Health of People with Severe and Persistent Mental Illness
    NHMRC Early Career Fellowships
    Open grant
  • 2016 - 2019
    N-Acetyl Cysteine In Schizophrenia Resistant to Clozapine: A Double-Blind Randomised Placebo-Controlled Trial Targeting Negative Symptoms (NHMRC Project grant administed by Uni Melbourne)
    University of Melbourne
    Open grant
  • 2015 - 2017
    Vaporising smoking-related harms in people with severe and persistent mental illness: A study of the acceptability of vaporised nicotine products for smoking cessation or long-term substitution
    Monash University
    Open grant
  • 2015 - 2017
    Quantifying the burden of perinatal depression in Australia and New Zealand
    RANZCP Pat, Toni and Peter Kinsman Research Scholarship
    Open grant
  • 2013 - 2016
    A MAP to better care: Applying the principles of advanced directives and motivational interviewing to discharge planning for psychiatric patients
    Australian Centre for Health Services Innovation
    Open grant

Supervision

Availability

Professor Dan Siskind is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Media

Enquiries

Contact Professor Dan Siskind directly for media enquiries about:

  • Cardiometabolic co-morbidity of schizophrenia
  • Treatment Refractory Schizophrenia

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au